Exploration of Health Literacy in Diabetes in Reunion Island and France
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · May 29, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with type 1, 2 or gestational diabetes taken care in hospital
- Exclusion Criteria:
- • Patient unable to understand and respect study procedures
- • Patient with cognitive disorder
- • Patient with serious acute complication due to diabetes within 15 days before inclusion
- • Stroke history with neurologic consequences
- • Other specific types of diabetes : chronic calcific pancreatitis, iatrogenic, other secondary diabetes, rare monogenic or genetic diabetes due to insulin resistance
About Centre Hospitalier Universitaire De La Réunion
The Centre Hospitalier Universitaire de la Réunion (CHU Réunion) is a leading academic medical center located on the island of Réunion. As a prominent clinical trial sponsor, CHU Réunion is dedicated to advancing medical research and improving patient care through innovative therapeutic studies and collaborations. With a focus on multidisciplinary approaches, the institution leverages its expertise in various medical fields to address pressing health challenges, enhance clinical practices, and promote evidence-based medicine. CHU Réunion is committed to ensuring patient safety and ethical standards in all research endeavors, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Denis, , Réunion
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0